Author

G. Timelthaler

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

A. de Bruin· 1 shared A. Tiefenbacher· 1 shared A. Villunger· 1 shared B. H. Ramsahoye· 1 shared B. Westendorp· 1 shared C. Bock· 1 shared C. H. Dietz· 1 shared C. Seiser· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. de Bruin

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMay 13, 2020

PIDDosome-induced p53-activation for ploidy restriction facilitates hepatocarcinogenesis

V. C. Sladky, K. Knapp, T. G. Szabo…·A. Villunger

This study shows that PIDDosome-mediated ploidy restriction prevents hepatocellular carcinoma by reducing tumor burden and that low ploidy predicts poor survival in HCC patients.

DOI 10.1101/2020.05.13.092486

mousehuman

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 9, 2020

Requirement of DNMT1 to orchestrate epigenomic reprogramming during NPM-ALK driven T cell lymphomagenesis

E. Redl, R. Sheibani-Tezerji, P. Hamminger…·G. Egger

This study shows that DNMT1 is essential for maintaining tumor-specific methylation during NPM-ALK driven T cell lymphomagenesis, despite oncogenic signaling.

DOI 10.1101/2020.04.09.033373

mouseDNA methylation

𝕏 PostBluesky